Received: 16 August 2021
Accepted: 28 January 2022
First Online: 22 February 2022
: The Mackay Memorial Hospital Review Board approved the animal study. All animal procedures were conducted in accordance with the ARVO Statement and the ARRIVE Guidelines for the use of animals in ophthalmic research. The animals were purchased from Lasco Co., Ltd. (Taiwan).Experimental procedures were approved by the Mackay Memorial Hospital Review Board (New Taipei City, Taiwan) and were performed in compliance with national animal welfare regulations (Council of Agriculture, R.O.C).
: Not applicable.
: YPT and TCH have competing financial interests. SIY, TWC and SLC have no competing interests as defined by BMC. The findings described in this manuscript have been patented by Mackay Memorial Hospital. The patent has subsequently been licensed to Oculus Biomed Pty Ltd. (OBM), based in Melbourne, Australia.